Skip to content
Sexual & HormonalGrade AMultiple human RCTs3 primary sources

Cosyntropin

Also known as tetracosactide · Synacthen · Cortrosyn · ACTH(1-24)

The first 24 amino acids of ACTH, used as the standard diagnostic test of adrenal function. Approved, well characterised, and used as a single dose.

Overview

ACTH is the pituitary hormone that tells the adrenal glands to make cortisol. Only the first 24 of its 39 amino acids are needed for that signal — the rest carry the species differences and much of the immune reactivity. Cosyntropin is that active portion. Give it, measure cortisol half an hour later, and you learn whether the adrenal glands can respond. If they cannot, adrenal insufficiency is confirmed.

Research areas

Adrenal insufficiencyHPA axis testingCongenital adrenal hyperplasia

Dosing reported in the literature

Every protocol below is reproduced from a published study or approved labelling, with its source named. These are records of what was studied — not recommendations, and not a suggestion that any of them is appropriate for any person.

Protocol as reportedSource
250 mcg intravenously or intramuscularly with cortisol measured at 0, 30 and 60 minutesStandard short synacthen test protocol
1 mcg intravenously in the low-dose test, proposed as more sensitive for partial secondary adrenal insufficiencyLow-dose ACTH stimulation test literature

Trial status

Long-established diagnostic standard with an extensive validation literature.

Reported safety signals

  • Hypersensitivity reactions including anaphylaxis have been reported, more often in people with existing allergic disease.
  • Recent glucocorticoid administration will confound the result.
  • It is a diagnostic agent — it has no established role as a therapeutic outside the specific depot indications.

Common questions

Why is Semax related to cosyntropin?

Both derive from ACTH. Cosyntropin keeps the hormonally active 1-24 region and is used to stimulate cortisol. Semax is the 4-10 fragment, which lacks the region needed to trigger cortisol release and was developed for its behavioural effects instead.

Primary sources

3 citations
  1. 01

    Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline

    Journal of Clinical Endocrinology & Metabolism2016

  2. 02

    The low-dose ACTH stimulation test for the diagnosis of adrenal insufficiency: a systematic review

    Journal of Clinical Endocrinology & Metabolism2008

  3. 03

    Cortrosyn (cosyntropin) prescribing information

    FDA Drugs@FDA2020

Medical disclaimer

This page is for informational and research purposes only. Nothing here constitutes medical advice. The compounds discussed are research chemicals. Consult a qualified clinician before starting any protocol.

How this profile was built →